DFMO and retinoic acid induce two different types of morphological changes in a human neuroblastoma cell line

L. Ghibelli, M. G. Farrace, P. Guerrieri, G. Melino, M. Piacentini

Research output: Contribution to journalArticlepeer-review

Abstract

The human neuroblastoma SK-N-BE(2) cell line, treated with either retinoic acid (RA) or α-difluoromethylornithine (DFMO) has already proved to be a suitable system to analyze stable in vitro differentiation towards neurocrest specific cell types. With the present study we show that the expression of the Nmyc oncogene is reduced in both RA and DFMO induced cell populations. This is a typical indication of cell differentiation in the nervous system. Ultrastructural analysis shows that the cells treated with either of the two agents undergo morphological changes that render them different between themselves as well as with the untreated population. The changes go in the direction of neural characteristics for RA treated cells, and Schwannian-like characteristics for DFMO induced cells. These results confirm our previous morphological and biochemical observations.

Original languageEnglish
Pages (from-to)299-307
Number of pages9
JournalClinical Chemistry and Enzymology Communications
Volume2
Issue number4-6
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'DFMO and retinoic acid induce two different types of morphological changes in a human neuroblastoma cell line'. Together they form a unique fingerprint.

Cite this